CD34 and plasma cell myeloma: Moreover myeloma cells display a very low retroviral-mediated transduction rate, even after repeated infection cycles (1.5–5.4%) [14,15], therefore we structured the protocol to allow the insertion and the expression of retroviral genes in the CD34+ cells.